Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Adv Protein Chem Struct Biol. 2017 Aug 24;111:197–222. doi: 10.1016/bs.apcsb.2017.07.005

Figure 4.

Figure 4.

Structures of the inhibitors of the E1-E2 interface. The repaglinide like class of inhibitors was found to have undesirable hypoglycemic effects, resulting from the chemical similarity to repaglinide.